Sapiens [SPNS] vs Salesforce [CRM] Detailed Stock Comparison
Sapiens
NASDAQ
Loading...
Salesforce
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sapiens wins in 10 metrics, Salesforce wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Sapiens | Salesforce | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 34.98 | 37.88 | Sapiens |
| Price-to-Book Ratio | 4.79 | 3.83 | Salesforce |
| Debt-to-Equity Ratio | 8.86 | 19.81 | Sapiens |
| PEG Ratio | -1.44 | 19.95 | Sapiens |
| EV/EBITDA | 24.69 | 20.20 | Salesforce |
| Profit Margin (TTM) | 12.45% | 16.08% | Salesforce |
| Operating Margin (TTM) | 11.86% | 20.12% | Salesforce |
| EBITDA Margin (TTM) | 11.86% | 20.12% | Salesforce |
| Return on Equity | 14.12% | 10.31% | Sapiens |
| Return on Assets (TTM) | 7.23% | 5.09% | Sapiens |
| Free Cash Flow (TTM) | $72.21M | $12.43B | Salesforce |
| Dividend Yield | 3.34% | 0.62% | Sapiens |
| 1-Year Return | 18.38% | -6.88% | Sapiens |
| Price-to-Sales Ratio (TTM) | 4.35 | 6.01 | Sapiens |
| Enterprise Value | $2.37B | $226.38B | Salesforce |
| EV/Revenue Ratio | 4.32 | 5.87 | Sapiens |
| Gross Profit Margin (TTM) | 43.71% | 76.96% | Salesforce |
| Revenue per Share (TTM) | $10 | $40 | Salesforce |
| Earnings per Share (Diluted) | $1.22 | $6.40 | Salesforce |
| Beta (Stock Volatility) | 0.95 | 1.37 | Sapiens |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Sapiens vs Salesforce Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sapiens | 0.00% | 0.09% | 41.05% | 53.08% | 52.81% | 63.70% |
| Salesforce | -0.25% | 5.34% | -6.27% | -12.91% | -20.65% | -25.65% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sapiens | 18.38% | 96.46% | 25.29% | 267.87% | 1,823.87% | 2,233.88% |
| Salesforce | -6.88% | 48.78% | -9.32% | 249.94% | 782.06% | 5,010.81% |
Performance & Financial Health Analysis: Sapiens vs Salesforce
| Metric | SPNS | CRM |
|---|---|---|
| Market Information | ||
| Market Cap | $2.39B | $231.77B |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 3,197,520 | 9,043,110 |
| 90 Day Avg. Volume | 1,213,870 | 6,980,807 |
| Last Close | $42.71 | $245.83 |
| 52 Week Range | $23.69 - $42.76 | $226.48 - $369.00 |
| % from 52W High | -0.12% | -33.38% |
| All-Time High | $110.00 (Jan 24, 2000) | $369.00 (Dec 02, 2024) |
| % from All-Time High | -61.17% | -33.38% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.08% |
| Quarterly Earnings Growth | -0.24% | 0.01% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.16% |
| Operating Margin (TTM) | 0.12% | 0.20% |
| Return on Equity (TTM) | 0.14% | 0.10% |
| Debt to Equity (MRQ) | 8.86 | 19.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.92 | $63.33 |
| Cash per Share (MRQ) | $1.33 | $18.21 |
| Operating Cash Flow (TTM) | $82.42M | $13.32B |
| Levered Free Cash Flow (TTM) | $51.63M | $14.43B |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.34% | 0.62% |
| Last 12-Month Dividend | $0.95 | $1.62 |
Valuation & Enterprise Metrics Analysis: Sapiens vs Salesforce
| Metric | SPNS | CRM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 34.98 | 37.88 |
| Forward P/E | 27.01 | 21.78 |
| PEG Ratio | -1.44 | 19.95 |
| Price to Sales (TTM) | 4.35 | 6.01 |
| Price to Book (MRQ) | 4.79 | 3.83 |
| Market Capitalization | ||
| Market Capitalization | $2.39B | $231.77B |
| Enterprise Value | $2.37B | $226.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.32 | 5.87 |
| Enterprise to EBITDA | 24.69 | 20.20 |
| Risk & Other Metrics | ||
| Beta | 0.95 | 1.37 |
| Book Value per Share (MRQ) | $8.92 | $63.33 |
Financial Statements Comparison: Sapiens vs Salesforce
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SPNS | CRM |
|---|---|---|
| Revenue/Sales | $136.11M | $9.83B |
| Cost of Goods Sold | $75.45M | $4.53B |
| Gross Profit | $60.66M | $7.56B |
| Research & Development | $16.28M | $1.46B |
| Operating Income (EBIT) | $21.20M | $1.98B |
| EBITDA | $26.06M | $2.92B |
| Pre-Tax Income | $22.53M | $1.97B |
| Income Tax | $4.49M | $433.00M |
| Net Income (Profit) | $18.03M | $1.54B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SPNS | CRM |
|---|---|---|
| Cash & Equivalents | $143.36M | $10.93B |
| Total Current Assets | $327.39M | $25.87B |
| Total Current Liabilities | $194.94M | $24.20B |
| Long-Term Debt | $16.06M | $10.78B |
| Total Shareholders Equity | $474.34M | $60.67B |
| Retained Earnings | N/A | $17.50B |
| Property, Plant & Equipment | $30.98M | $5.26B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SPNS | CRM |
|---|---|---|
| Operating Cash Flow | $25.14M | $6.89B |
| Capital Expenditures | $-366,000 | N/A |
| Free Cash Flow | $23.04M | $6.30B |
| Debt Repayment | $-19.80M | $-179.00M |
| Common Stock Repurchase | N/A | $-2.63B |
Short Interest & Institutional Ownership Analysis
| Metric | SPNS | CRM |
|---|---|---|
| Shares Short | 803,042 | 13.69M |
| Short Ratio | 4.14 | 2.29 |
| Short % of Float | 0.03% | 0.01% |
| Average Daily Volume (10 Day) | 3,197,520 | 9,043,110 |
| Average Daily Volume (90 Day) | 1,213,870 | 6,980,807 |
| Shares Outstanding | 55.89M | 962.00M |
| Float Shares | 30.63M | 930.65M |
| % Held by Insiders | 0.45% | 0.03% |
| % Held by Institutions | 0.37% | 0.83% |
Dividend Analysis & Yield Comparison: Sapiens vs Salesforce
| Metric | SPNS | CRM |
|---|---|---|
| Last 12-Month Dividend | $0.95 | $1.62 |
| Last 12-Month Dividend Yield | 3.34% | 0.62% |
| 3-Year Avg Annual Dividend | $0.66 | $0.67 |
| 3-Year Avg Dividend Yield | 1.22% | 0.15% |
| 3-Year Total Dividends | $1.97 | $2.02 |
| Ex-Dividend Date | Apr 07, 2025 | Apr 10, 2025 |